When I pull up a quote for Neuren, it shows a PE of 25 based upon EPS of 0.44 and a stock price of $11. The product of the EPS and the PE is $11. So someone in investor land is bestowing a PE of 25. Questions for the Board - is there any legitimacy to an EPS of 0.44? Is that past or projected earnings, and shouldn’t it be projected earnings? With Acadia announcing Q3 at or about November 2 along with projected Q4, what would the share price be based upon a forward looking PE of 25, and with whatever methodology is currently at play? Thank you in advance.
Share Price, page-7271
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.21 |
Change
-0.130(0.85%) |
Mkt cap ! $1.944B | |||
| Open | High | Low | Value | Volume |
| $15.19 | $15.47 | $15.07 | $6.450M | 422.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1938 | $15.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.29 | 54 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |